TianYu Bio-Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	145.92	178.05	151.6	287.73	305.66	181.46
Cash & Short-Term Investments	145.92	178.05	151.6	287.73	305.66	181.46
Cash Growth	-11.73%	17.44%	-47.31%	-5.87%	68.44%	-43.41%
Accounts Receivable	494.1	735.89	893.69	1,033	1,382	1,495
Other Receivables	376.62	258.93	307.38	294.37	296.99	229.39
Receivables	870.72	994.82	1,201	1,327	1,679	1,724
Inventory	218.73	223.77	159.63	239.74	105.95	74.45
Other Current Assets	60.26	56.16	115.17	59.85	132.42	83.03
Total Current Assets	1,296	1,453	1,627	1,914	2,223	2,063
Property, Plant & Equipment	525.98	533.56	521.79	361.86	233.26	172.62
Long-Term Investments	102.35	97.5	101.67	255.83	96.63	188.67
Goodwill	2.08	2.08	5.56	5.56	5	5
Other Intangible Assets	25.4	26.15	7.12	7.82	104.93	103.6
Long-Term Accounts Receivable	615.16	613.03	452.24	309.12	129.08	480.23
Long-Term Deferred Tax Assets	102.48	105.4	109.43	92.12	46.83	24.57
Long-Term Deferred Charges	4.02	4.95	5.3	4.65	3.59	18.16
Other Long-Term Assets	320.56	279.51	342.06	409.89	486.69	261.75
Total Assets	2,994	3,215	3,273	3,461	3,329	3,318
Accounts Payable	592.19	638.33	684	666.01	684.18	741.21
Accrued Expenses	30.74	28.24	19.38	16.59	6.62	7.53
Short-Term Debt	79.08	128.23	168.35	152.76	216.34	344.07
Current Portion of Long-Term Debt	-	115.51	77.61	39.39	311.02	63.04
Current Portion of Leases	-	35.94	25.94	33.71	6.31	79.4
Current Income Taxes Payable	0.67	0.05	-	1.35	2.28	2.15
Current Unearned Revenue	95.33	144.65	82.5	71.63	80.07	105.22
Other Current Liabilities	264.68	255.4	180.37	149.4	117.15	137.97
Total Current Liabilities	1,063	1,346	1,238	1,131	1,424	1,481
Long-Term Debt	943.42	753.37	751.37	649.16	212.11	460.95
Long-Term Leases	65.48	247.13	281.18	209.79	41	4
Long-Term Unearned Revenue	0.63	0.69	-	-	-	-
Long-Term Deferred Tax Liabilities	2.51	2.68	0.07	0.26	0.58	1.05
Other Long-Term Liabilities	212.61	156.24	167.5	36.79	39.59	10.51
Total Liabilities	2,287	2,506	2,438	2,027	1,717	1,957
Common Stock	290.15	290.15	290.15	290.15	290.15	241.8
Additional Paid-In Capital	912.8	912.21	931.77	931.9	930.16	585.65
Retained Earnings	-685.23	-683.62	-576.26	-81.85	197.55	412.3
Total Common Equity	517.72	518.74	645.66	1,140	1,418	1,240
Minority Interest	188.61	189.79	188.69	293.53	193.73	120.75
Shareholders' Equity	706.33	708.53	834.35	1,434	1,612	1,360
Total Liabilities & Equity	2,994	3,215	3,273	3,461	3,329	3,318
Total Debt	1,088	1,280	1,304	1,085	786.78	951.46
Net Cash (Debt)	-942.05	-1,102	-1,153	-797.09	-481.12	-770
Net Cash Per Share	-3.25	-3.80	-3.97	-3.30	-1.81	-3.18
Filing Date Shares Outstanding	290.15	290.15	290.15	290.15	290.15	241.8
Total Common Shares Outstanding	290.15	290.15	290.15	290.15	290.15	241.8
Working Capital	232.94	106.45	389.31	783.56	798.86	582.38
Book Value Per Share	1.78	1.79	2.23	3.93	4.89	5.13
Tangible Book Value	490.24	490.5	632.98	1,127	1,308	1,131
Tangible Book Value Per Share	1.69	1.69	2.18	3.88	4.51	4.68
Buildings	-	150.56	98.24	7.96	176.46	162.88
Machinery	-	245.82	209.27	88.56	31.86	34.28
Construction In Progress	-	21.37	19.06	7.37	3.93	1.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.